elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34449725-14A2F3A9-EB1E-4C8A-82C6-D2062FE329FE
Q34449725-14A2F3A9-EB1E-4C8A-82C6-D2062FE329FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34449725-14A2F3A9-EB1E-4C8A-82C6-D2062FE329FE
Review of the regulations for clinical research in herbal medicines in USA.
P2860
Q34449725-14A2F3A9-EB1E-4C8A-82C6-D2062FE329FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34449725-14A2F3A9-EB1E-4C8A-82C6-D2062FE329FE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
baf5bf07897b1402fcf07fb531fa3f2809f5bf62
P2860
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial.